NCT06497777View on ClinicalTrials.gov

The Application of DNA Nanomachines for Detecting microRNA in Blood for the Diagnosis of Pancreatic Cancer. Diagnosis of Pancreatic Cancer

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

July 6, 2024

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2026

Conditions
Pancreas AdenocarcinomaMicroRNA
Interventions
GENETIC

MicroRNA (mir-642b-3p)

A circulating microRNA in the blood of pancreatic cancer patients.

Trial Locations (1)

100225

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER